Back

Differences in high-sensitivity troponin assay and association with myocardial injury and periprocedural MI after PCI for de novo three-vessel disease: insights from Multivessel TALENT

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Contemporary PCI strategies in acute coronary syndromes: from diagnosis to optimisation Revascularisation EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Nozomu Kanehama

University of Galway, Galway (Ireland)

4 More presentations in this session

Presentation thumbnail
Cross-sectional analysis of primary PCI provision and AMI mortality across europe: accounting for economic and disease burden
Mr A. Malik (London, GB)
Abstract Slides
Presentation thumbnail
Breaking stereotypes: baseline features, treatment strategies, and 12-month outcomes in SCAD AMI patients: findings from the Serbian SCAD registry (SR SCAD)
Professor S. Apostolovic (Nis, RS)
Abstract Slides
Presentation thumbnail
Impact of different infusion routes in STEMI patients with high thrombotic risk
Doctor H. Tokdil (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Intracoronary vasoactive therapy for no-reflow during primary PCI
Doctor F. Oliveri (Leiden, NL)
Abstract Slides

Access the full session

Session thumbnail
Contemporary PCI strategies in acute coronary syndromes: from diagnosis to optimisation

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources